Skip to main content
. 2022 Nov 24;11(23):6923. doi: 10.3390/jcm11236923

Table 4.

Diagnostic performance of the panel of three plasma cytokine biomarkers for lung cancer in the two cohorts.

The Development Cohort The Validation Cohort
p-value <0.0001 <0.0001
AUC (95% CI) 0.7924 (0.7209 to 0.8639) 0.7781 (0.7017 to 0.8545)
Sensitivity (%) (95% CI) 80.62.78 (72.74% to 87.05%) 78.26 (71.09% to 84.37%)
Specificity (%) (95% CI) 82.00 (68.56% to 91.42%) 80.65 (62.53% to 92.55%)

AUC, the area under receiver operating characteristic curve; CI, confidence interval.